Animesh Pardanani

Animesh Pardanani

UNVERIFIED PROFILE

Are you Animesh Pardanani?   Register this Author

Register author
Animesh Pardanani

Animesh Pardanani

Publications by authors named "Animesh Pardanani"

Are you Animesh Pardanani?   Register this Author

100Publications

2223Reads

5Profile Views

WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic.

Am J Hematol 2020 Jul 17;95(7):E172-E174. Epub 2020 Apr 17.

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25811DOI Listing
July 2020

81-Year-Old Man With Insomnia and Pruritus.

Mayo Clin Proc 2020 Jun;95(6):e59-e64

Advisor to residents and Consultant in Hematology, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.10.044DOI Listing
June 2020

Erythrocytosis associated with cerebral hemangiomas and multiple venous anomalies.

Am J Hematol 2020 Jun 29. Epub 2020 Jun 29.

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25913DOI Listing
June 2020

Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies.

Am J Hematol 2020 05 17;95(5):E114-E117. Epub 2020 Feb 17.

Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25748DOI Listing
May 2020

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.

Br J Haematol 2020 Apr 16;189(2):291-302. Epub 2020 Jan 16.

Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, and Denothe Excellence Center, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16380DOI Listing
April 2020

Essential Thrombocythemia. Reply.

N Engl J Med 2020 03;382(12):e21

Mayo Clinic, Rochester, MN

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1917586DOI Listing
March 2020

Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience.

Ann Diagn Pathol 2020 Feb 18;44:151412. Epub 2019 Oct 18.

Division of Hematopathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2019.151412DOI Listing
February 2020

Essential Thrombocythemia.

N Engl J Med 2019 11;381(22):2135-2144

From the Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcp1816082DOI Listing
November 2019

Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies.

Leukemia 2019 10 1;33(10):2522-2553. Epub 2019 May 1.

Divisions of Laboratory Genetics and Genomics, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0453-5DOI Listing
October 2019

Mutations and prognosis in myeloproliferative neoplasms.

Leuk Lymphoma 2019 05 14;60(5):1112-1113. Epub 2018 Nov 14.

a Division of Hematology, Department of Internal Medicine , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1537490DOI Listing
May 2019

Calculator-free point-of-care prognostication in myelodysplastic syndromes.

Am J Hematol 2019 04 24;94(4):E99-E101. Epub 2019 Jan 24.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25400
Publisher Site
http://dx.doi.org/10.1002/ajh.25400DOI Listing
April 2019

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis.

Leukemia 2019 03 12;33(3):780-785. Epub 2018 Oct 12.

Divisions of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0283-xDOI Listing
March 2019

Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.

Am J Hematol 2019 03 2;94(3):363-377. Epub 2019 Jan 2.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25371
Publisher Site
http://dx.doi.org/10.1002/ajh.25371DOI Listing
March 2019

World Health Organization class-independent risk categorization in mastocytosis.

Blood Cancer J 2019 03 4;9(3):29. Epub 2019 Mar 4.

Divisions of Hematology, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-019-0189-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399221PMC
March 2019

Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis.

Am J Hematol 2019 01 9;94(1):E1-E2. Epub 2018 Nov 9.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25302
Publisher Site
http://dx.doi.org/10.1002/ajh.25302DOI Listing
January 2019

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis.

Br J Haematol 2018 12 19;183(5):835-838. Epub 2017 Dec 19.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15061DOI Listing
December 2018

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm.

Am J Hematol 2018 12 17;93(12):E383-E386. Epub 2018 Oct 17.

Divisions of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25269DOI Listing
December 2018

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger.

Am J Hematol 2018 12 27;93(12):1474-1484. Epub 2018 Sep 27.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25270DOI Listing
December 2018

Mutations and karyotype predict treatment response in myelodysplastic syndromes.

Am J Hematol 2018 11 30;93(11):1420-1426. Epub 2018 Sep 30.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25267DOI Listing
November 2018

Genetic predictors of response to specific drugs in primary myelofibrosis.

Blood Cancer J 2018 11 19;8(12):120. Epub 2018 Nov 19.

Divisions of Hematology, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0158-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242902PMC
November 2018

MPL-mutated essential thrombocythemia: a morphologic reappraisal.

Blood Cancer J 2018 11 20;8(12):121. Epub 2018 Nov 20.

Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0159-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246562PMC
November 2018

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.

Leukemia 2018 10 27;32(10):2274-2278. Epub 2018 Feb 27.

Division of Hematology, Departments of Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0078-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170397PMC
October 2018

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis.

Am J Hematol 2018 09 31;93(9):E235-E238. Epub 2018 Aug 31.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25203DOI Listing
September 2018

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.

Br J Haematol 2018 08 5;182(4):594-597. Epub 2017 Jul 5.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14838DOI Listing
August 2018

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance.

Br J Haematol 2018 08 9;182(3):437-440. Epub 2017 Jun 9.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14798DOI Listing
August 2018

JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease.

Am J Hematol 2018 08;93(4):E93-E96

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25017
Publisher Site
http://dx.doi.org/10.1002/ajh.25017DOI Listing
August 2018

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis.

Am J Hematol 2018 08 27;93(4):E103-E107. Epub 2018 Jan 27.

Divisions of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25037
Publisher Site
http://dx.doi.org/10.1002/ajh.25037DOI Listing
August 2018

How I treat myelofibrosis after failure of JAK inhibitors.

Blood 2018 08 4;132(5):492-500. Epub 2018 Jun 4.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-02-785923DOI Listing
August 2018

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.

Leukemia 2018 07 23;32(7):1631-1642. Epub 2018 Mar 23.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0107-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035151PMC
July 2018

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.

Am J Hematol 2018 07 6;93(7):E164-E167. Epub 2018 May 6.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25114DOI Listing
July 2018

Myelofibrosis Treatment Algorithm 2018.

Blood Cancer J 2018 07 31;8(8):72. Epub 2018 Jul 31.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0109-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068139PMC
July 2018

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates.

Am J Hematol 2018 Jun 6;93(6):E146-E148. Epub 2018 Apr 6.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25084DOI Listing
June 2018

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis.

J Clin Oncol 2018 06 30;36(17):1769-1770. Epub 2018 Apr 30.

Ayalew Tefferi, Mayo Clinic, Rochester, MN; Paola Guglielmelli, University of Florence, Florence, Italy; Terra L. Lasho, Naseema Gangat, Rhett P. Ketterling, and Animesh Pardanani, Mayo Clinic, Rochester, MN; and Alessandro M. Vannucchi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.9867DOI Listing
June 2018

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis.

Blood Cancer J 2018 06 11;8(6):57. Epub 2018 Jun 11.

Department of Internal Medicine and Laboratory Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0095-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996023PMC
June 2018

Mayo CALR mutation type classification guide using alpha helix propensity.

Am J Hematol 2018 05 24;93(5):E128-E129. Epub 2018 Feb 24.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25065DOI Listing
May 2018

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.

Am J Hematol 2018 03 18;93(3):348-355. Epub 2017 Dec 18.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24978DOI Listing
March 2018

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

J Clin Oncol 2018 02 9;36(4):310-318. Epub 2017 Dec 9.

Paola Guglielmelli, Giada Rotunno, Carmela Mannarelli, Annalisa Pacilli, Francesco Mannelli, and Alessandro M. Vannucchi, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence; Elisa Rumi, Vittorio Rosti, Giovanni Barosi, and Mario Cazzola, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo; Elisa Rumi and Mario Cazzola, University of Pavia, Pavia; Alessandro Rambaldi, University of Milan, Milan; Alessandro Rambaldi and Tiziano Barbui, Azienda Socio sanitaria Territoriale Papa Giovanni XXIII, Bergamo; Francesco Passamonti, University of Insubria, Varese, Italy; and Terra L. Lasho, Mythri Mudireddy, Maura Nicolosi, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, and Ayalew Tefferi, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4886DOI Listing
February 2018

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.

Am J Hematol 2017 Dec 20;92(12):1311-1317. Epub 2017 Oct 20.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24901DOI Listing
December 2017

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.

Blood Cancer J 2017 12 18;7(12):657. Epub 2017 Dec 18.

Division of Hematology, Department of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41408-017-0024-9
Publisher Site
http://dx.doi.org/10.1038/s41408-017-0024-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802557PMC
December 2017

Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.

Am J Hematol 2017 Nov 24;92(11):1187-1192. Epub 2017 Aug 24.

Department of, Surgery, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24881DOI Listing
November 2017

Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.

Am J Hematol 2017 Nov 28;92(11):1193-1197. Epub 2017 Aug 28.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24882DOI Listing
November 2017

Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.

JCO Precis Oncol 2017 1;2017. Epub 2017 Aug 1.

David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala'Aldeen, Jean-Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. Tagtow, Sikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Asher A. Chanan-Khan, Ronald S. Go, Thorvardur R. Halfdanarson, Richard W. Joseph, Prashant Kapoor, Aaron S. Mansfield, Amulya A. Nageswara Rao, Grzegorz S. Nowakowski, Animesh Pardanani, Sameer A. Parikh, John C. Cheville, Andrew L. Feldman, Ramesh K. Ramanathan, Steven I. Robinson, Heidi D. Finnes, Jennifer B. McCormick, Robert R. McWilliams, Aminah Jatoi, Mrinal M. Patnaik, Eric D. Wieben, Tammy M. McAllister, Kandelaria M. Rumilla, Sarah E. Kerr, Konstantinos N. Lazaridis, Gianrico Farrugia, Karl J. Clark, Eric W. Klee, and Martin E. Fernandez-Zapico, Mayo Clinic, Rochester; Ernesto Resnik, Bio-Techne, Minneapolis, MN; Sikander Ailawadhi, Asher A. Chanan-Khan, and Richard W. Joseph, Mayo Clinic, Jacksonville, FL; Jan B. Egan, Alan H. Bryce, Estrella M. Carballido, KellyK. Curtis, Chelsea D. Gawryletz, Thai H. Ho,Nathalie Meurice, Ramesh K. Ramanathan, Raoul Tibes, Alvin C. Silva, A. Keith Stewart, and Mitesh J. Borad, Mayo Clinic, Phoenix, AZ; and Eileen J. Kennedy, University of Georgia, Athens, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369924PMC
August 2017

Monocytosis in polycythemia vera: Clinical and molecular correlates.

Am J Hematol 2017 Jul 26;92(7):640-645. Epub 2017 May 26.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24740DOI Listing
July 2017

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.

Am J Hematol 2017 May 20;92(5):454-459. Epub 2017 Mar 20.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24689
Publisher Site
http://dx.doi.org/10.1002/ajh.24689DOI Listing
May 2017

Targeted deep sequencing in primary myelofibrosis.

Blood Adv 2016 Dec 30;1(2):105-111. Epub 2016 Nov 30.

Division of Hematology, Department of Internal Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2016000208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737166PMC
December 2016

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.

Am J Hematol 2016 Nov;91(11):1146-1159

Division of Hematology Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24553DOI Listing
November 2016

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis.

Br J Haematol 2016 11 2;175(3):534-536. Epub 2015 Dec 2.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13865DOI Listing
November 2016

Targeted deep sequencing in polycythemia vera and essential thrombocythemia.

Blood Adv 2016 Nov 22;1(1):21-30. Epub 2016 Nov 22.

Centro Ricerca e Innovazione Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; and.

View Article

Download full-text PDF

Source
http://www.bloodadvances.org/lookup/doi/10.1182/bloodadvance
Publisher Site
http://dx.doi.org/10.1182/bloodadvances.2016000216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744051PMC
November 2016

Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.

Am J Hematol 2016 09 20;91(9):888-93. Epub 2016 Jun 20.

Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24426DOI Listing
September 2016

Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors.

Ann Hematol 2016 Jun 23;95(7):1185-9. Epub 2016 Apr 23.

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2674-2DOI Listing
June 2016

BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia.

Cancer Genet 2016 May 6;209(5):223-8. Epub 2016 Apr 6.

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2016.03.002DOI Listing
May 2016